Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun-ichi Oyama

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Circulation Journal : Official Journal of the Japanese Circulation Society|March 12, 2014
Incretin therapy and heart failureJun-Ichi Oyama, Koichi Node
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 26, 2018
Is GRK2 a new target for cardiovascular disease?Jun-Ichi Oyama, Koichi Node
Internal Medicine (Tokyo, Japan)|May 17, 2019
Rheumatoid Arthritis and Vascular Failure - Rheumatoid Arthritis Is a Risk Factor for Cardiovascular DiseaseJun-Ichi Oyama, Koichi Node
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 19, 2014
Sympathetic nerve activity and endothelial functionJun-ichi Oyama, Koichi Node
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 23, 2013
Endothelium-derived hyperpolarizing factor and hypertensionJun-Ichi Oyama, Koichi Node
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 24, 2017
Prevalence of prehypertension and left ventricular hypertrophyJun-Ichi Oyama, Koichi Node
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 13, 2019
Gut microbiota and hypertensionJun-Ichi Oyama, Koichi Node
Cardiovascular Diabetology|January 17, 2014
Do incretins improve endothelial function?Jun-Ichi Oyama, Yukihito Higashi, Koichi Node
International Journal of Cardiology|April 17, 2015
The effects and safety of vildagliptin on cardiac function after acute myocardial infarctionToshiyuki Nishikido, Jun-ichi Oyama, Hiroshi Ohira, et al.
European Journal of Pharmacology|March 25, 2023
Linagliptin exacerbates heart failure due to energy deficiency via downregulation of glucose utilization and absorption in a mouse modelAya Shiraki, Jun-Ichi Oyama, Takahiko Shimizu, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Circulation Journal : Official Journal of the Japanese Circulation Society|March 12, 2014
Incretin therapy and heart failureJun-Ichi Oyama, Koichi Node
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 26, 2018
Is GRK2 a new target for cardiovascular disease?Jun-Ichi Oyama, Koichi Node
Internal Medicine (Tokyo, Japan)|May 17, 2019
Rheumatoid Arthritis and Vascular Failure - Rheumatoid Arthritis Is a Risk Factor for Cardiovascular DiseaseJun-Ichi Oyama, Koichi Node
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 19, 2014
Sympathetic nerve activity and endothelial functionJun-ichi Oyama, Koichi Node
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 23, 2013
Endothelium-derived hyperpolarizing factor and hypertensionJun-Ichi Oyama, Koichi Node
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 24, 2017
Prevalence of prehypertension and left ventricular hypertrophyJun-Ichi Oyama, Koichi Node
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 13, 2019
Gut microbiota and hypertensionJun-Ichi Oyama, Koichi Node
Cardiovascular Diabetology|January 17, 2014
Do incretins improve endothelial function?Jun-Ichi Oyama, Yukihito Higashi, Koichi Node
International Journal of Cardiology|April 17, 2015
The effects and safety of vildagliptin on cardiac function after acute myocardial infarctionToshiyuki Nishikido, Jun-ichi Oyama, Hiroshi Ohira, et al.
European Journal of Pharmacology|March 25, 2023
Linagliptin exacerbates heart failure due to energy deficiency via downregulation of glucose utilization and absorption in a mouse modelAya Shiraki, Jun-Ichi Oyama, Takahiko Shimizu, et al.
Pageof 8